AVI Polymers Ltd
- Market Cap ₹ 239 Cr.
- Current Price ₹ 25.4
- High / Low ₹ 29.4 / 5.43
- Stock P/E 11.8
- Book Value ₹ 12.3
- Dividend Yield 0.00 %
- ROCE 45.5 %
- ROE 33.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 127% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.8%
- Debtor days have improved from 359 to 149 days.
- Company's working capital requirements have reduced from 11,725 days to 104 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -24.1%
- Promoter holding is low: 1.10%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 4 | 1 | 1 | 0 | 1 | 4 | 5 | 4 | 1 | 0 | 312 | |
| 3 | 4 | 1 | 1 | 0 | 1 | 4 | 5 | 4 | 1 | 0 | 285 | |
| Operating Profit | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | -0 | 27 |
| OPM % | -1% | 1% | 11% | 0% | -48% | -1% | 3% | 7% | -2% | -30% | -350% | 9% |
| 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 28 |
| Tax % | 0% | 0% | 0% | 70% | 19% | 25% | 31% | 33% | 26% | 27% | ||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 20 | |
| EPS in Rs | 0.00 | 0.00 | 0.05 | 0.01 | 0.00 | 0.01 | 0.04 | 0.05 | 0.01 | 0.00 | 0.09 | 2.16 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 54% |
| 5 Years: | 140% |
| 3 Years: | 335% |
| TTM: | 520083% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 82% |
| 5 Years: | 127% |
| 3 Years: | 453% |
| TTM: | 2379% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 39% |
| 3 Years: | 55% |
| 1 Year: | 328% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 27% |
| 3 Years: | 30% |
| Last Year: | 33% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 94 |
| Reserves | -1 | -1 | -1 | -1 | -1 | -1 | -0 | 0 | 0 | 0 | 1 | 22 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |
| 0 | 0 | 0 | 0 | -0 | 0 | 1 | 1 | 0 | 0 | 0 | 59 | |
| Total Liabilities | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 5 | 6 | 6 | 176 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| 2 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 171 | |
| Total Assets | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 5 | 6 | 6 | 176 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1 | 1 | -0 | -0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | -63 | |
| 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -1 | -1 | 0 | -4 | |
| 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 83 | |
| Net Cash Flow | -0 | -0 | 0 | -0 | 0 | 0 | 0 | 1 | -1 | -0 | -0 | 17 |
| Free Cash Flow | -1 | 1 | -0 | -0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | -63 |
| CFO/OP | 3,650% | 1,380% | -107% | -146% | -2,300% | 15% | 333% | -157% | -100% | -386% | -230% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 168 | 99 | 424 | 502 | 1,419 | 421 | 167 | 182 | 96 | 570 | 0 | 149 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 659 | 8,638 | 27 |
| Days Payable | 12 | 61 | 67 | |||||||||
| Cash Conversion Cycle | 168 | 99 | 424 | 502 | 1,419 | 421 | 167 | 182 | 96 | 1,218 | 8,578 | 109 |
| Working Capital Days | 210 | 102 | 808 | 1,078 | 4,448 | 1,404 | 363 | 257 | 337 | 1,916 | 33,154 | 104 |
| ROCE % | 0% | 2% | 4% | 0% | 1% | 6% | 10% | 15% | 3% | 1% | 19% | 46% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees count |
|
|||||||||||
| Trade Receivables Turnover Ratio ratio |
||||||||||||
| Chemical Trading Contribution to Turnover % |
||||||||||||
| Sales Volume - Textile Pcs |
||||||||||||
| Sales Volume - Chemicals (MT) MT |
||||||||||||
| Sales Volume - Machines Nos. |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Approval Of Strategic Acquisition Via Share Swap And Expansion Of Core Business Objects.
7 May - Board approved 90% stake acquisition in JVTR Consultants via share swap, plus MOA expansion on May 7, 2026.
-
Business Update - Exceptional Early Traction For 'ASHWINI HEALTHCARE AI' (Www.Ashwini.Tech) With 5,620+ Registered Users; Outlining The SAAS Revenue Roadmap & Metrics.
6 May - Ashwini Healthcare AI soft-launched with 5,620+ users; ₹999 annual subscription and ARR roadmap outlined.
- Closure of Trading Window 4 May
-
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, May 07, 2026.
4 May - Board meets May 7, 2026 to consider ₹500 crore fund raise, acquisition proposal, and new IT objects.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
30 Apr - Official Launch of "AVI HEALTH AI" (ASHWINI.TECH) and Submission of Investor Presentation.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:
AVIPL specializes in polymer compounds
for cables, plastics, and textiles. The company deals in polymer trading and has also expanded
into the Specialty Chemical Industry. Currently, the company is a trading house, offering a portfolio that includes plastic & rubber compounds, dyes intermediates, and detergent chemicals